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Abstract
Background: Nanoparticles have emerged as key materials for developing applications in nanomedicine, nanobiotechnology, bioimaging and theranostics. Existing bioimaging technologies include bioluminescent resonance
energy transfer-conjugated quantum dots (BRET-QDs). Despite the current use of BRET-QDs for bioimaging, there are
strong concerns about QD nanocomposites containing cadmium which exhibits potential cellular toxicity.
Results: In this study, bioluminescent composites comprised of magnetic nanoparticles and firefly luciferase (Photinus pyralis) are examined as potential light-emitting agents for imaging, detection, and tracking mammalian spermatozoa. Characterization was carried out using infrared spectroscopy, TEM and cryo-TEM imaging, and ζ-potential
measurements to demonstrate the successful preparation of these nanocomposites. Binding interactions between
the synthesized nanoparticles and spermatozoon were characterized using confocal and atomic/magnetic force
microscopy. Bioluminescence imaging and UV–visible-NIR microscopy results showed light emission from sperm
samples incubated with the firefly luciferase-modified nanoparticles. Therefore, these newly synthesized luciferasemodified magnetic nanoparticles show promise as substitutes for QD labeling, and can potentially also be used for
in vivo manipulation and tracking, as well as MRI techniques.
Conclusions: These preliminary data indicate that luciferase-magnetic nanoparticle composites can potentially be
used for spermatozoa detection and imaging. Their magnetic properties add additional functionality to allow for
manipulation, sorting, or tracking of cells using magnetic techniques.
Keywords: Spermatozoa, Bioluminescence Imaging, Magnetic nanoparticles, Nanocomposites, Reproduction,
Core–shell nanoparticles, Luciferase
Background
Nanoparticle-based biomedical applications include
nanomedicine, bioimaging and theranostics [1]. Recently,
nanoparticle-based bioimaging technologies have
focused on bioluminescent resonance energy transferconjugated quantum dots (BRET-QDs), such as PbS,
CdSe/ZnS, and CdTe/CdS QDs [2–6]. However, BRETQDs are under scrutiny due to their cadmium content,
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since cadmium has known toxicity [7, 8]. An alternative
noninvasive bioimaging system could explore luciferase
enzymes, which are found in nature and has inherent
light emission characteristics, for bioluminescence imaging in whole animal and cellular systems. For example,
luciferase obtained from Renilla reniformis has been
coupled with CdSe/ZnS QDs to create self-illuminating
nanoparticles for dual imaging purposes. In this complex, the chemical energy generated by the reaction of
luciferase with its substrate (coelenterazine or luciferin)
produced light (bioluminescence) which excited the QD
for a bright fluorescence emission [9, 10]. Similarly, firefly Photinus pyralis luciferase has been combined with
core–shell quantum rods (CdSe/CdS or CdSe/CdS/ZnS),
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producing a significant increase and optimization in
BRET ratios [11].
In biomedical applications, core–shell nanostructures
comprised of a magnetic core present a unique opportunity for multi-functionality, incorporating optical imaging with tracking, sorting and/or cellular manipulation
[12, 13]. Superparamagnetic iron oxide nanoparticles are
clinically approved by the European Medicines Agency
(EMA) and U. S. Food and Drug Administration (FDA),
and have been used to label and track cells via MRI techniques [14]. For example, lectin-coated iron oxide nanoparticles have been successfully used to bind and remove
(under magnetic field) moribund mammalian spermatozoa without impairing the fertility potential of remaining
unbound spermatozoa [15, 16]. Recently, hybrid microhelixes made of a polymer-metal composite with magnetic properties have demonstrated the possible impacts
from using magnetic microstructures in assisted fertilization [17]. Magnetic nanoparticles have shown viability in labeling and tracking applications; however, we
are interested in using magnetic nanoparticles to enable
cell detection, labeling and sorting without further perturbation of their viability—which would be the case
when using fluorescent agents requiring additional excitation. In this study, coupling firefly luciferase (Photinus
pyralis) with a magnetic nanoparticle carrier is expected
to provide a multifunctional nanocomposite with both
magnetic manipulation and bioimaging properties. One
objective of this work is to describe the synthesis and
in situ characterization of core–shell nanocomposites
comprised of a citric acid-stabilized magnetic nanoparticle core surrounded by a spherical shell of the bioluminescent firefly luciferase (Photinus pyralis) enzyme. A
second objective is to analyze preliminary bioluminescence data from boar spermatozoa incubated with the
newly synthesized luciferase-modified magnetic nanoparticles (Luc + MNP). This analysis is presented using
chemical and morphological characterization of the
luciferase-magnetic nanoparticle composite and bioluminescence imaging, along with comparative data from
a commercial BRET-QD that served as bioluminescence
control.
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performing cell sorting through nanotechnology tools,
one advantage of using luciferase enzymes as imaging
probes resides on the avoidance of additional light excitation that may damage cells when using fluorescent probes
[18].
In situ ATR-FTIR spectroscopy was used to confirm
the chemical changes in the MNPs for each reaction step
(Fig. 1). For CA-MNPs, a strong peak at ~1645 cm−1
was observed corresponding to the symmetric carbonyl
(C = O) vibrations of the carboxylic acid groups (–COOH)
in citric acid when bound to iron oxide [19]. FTIR spectra of neat firefly luciferase showed distinctive peaks at
1550 cm−1 and 1515 cm−1, which are amide-II vibrations
characteristic of luciferase [20]. In addition, the peak near
1650 cm−1 corresponds to an amide-I band commonly
observed when multiple α- and β-functional groups are
present, and has been previously observed for luciferase
[21]. After addition of luciferase to the CA-MNPs complex, distinctive peaks were observed for the Luc + MNP
samples that match the spectral signature for neat luciferase and indicate strong binding between luciferase and
the CA-MNPs. Amide-II peaks observed in the neat luciferase spectra were also observed in the luciferase-CAMNP (Luc + MNP) spectra. In addition, the strong peaks
at ~1400 and ~1350 cm−1 and the broadening and slight
shift of the Amide-I peak is indicative of strong binding
interactions between the amide/amine groups of luciferase
and the carboxylic acid groups on the surface of the citricacid modified iron oxide nanoparticles [19].
Transmission electron microscopy (TEM) was used to
examine the structure and uniformity of the synthesized

Results and discussion
Conjugated nanoparticle preparation

Iron oxide magnetic nanoparticles (MNPs) were synthesized using a co-precipitation technique that is described
in detail in the methods section. After synthesis, MNPs
were stabilized with a citric acid coating to form the citric acid-magnetic nanoparticle (CA-MNP) conjugate.
A second reaction added the firefly luciferase enzyme
onto the periphery of the CA-MNP to form the luciferase-CA-MNP (Luc + MNP) complex. With the goal of

Fig. 1 FTIR spectra for a citric acid-coated magnetic nanoparticles
(CA-MNPs), b firefly luciferase (Luc), and c firefly luciferase combined
with CA-MNP (Luc + MNPs) confirm the successful surface modification steps
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nanocomposites. Figure 2a shows a high-resolution
TEM image of the as-synthesized CA-MNPs; homogeneous particles, approximately 17 nm in diameter, were
observed. Cryo-TEM was performed on CA-MNPs to
confirm the primary particle size and gain information
on the in situ nanoparticle dispersion (Fig. 2b). Samples imaged under cryogenic conditions showed a more
dispersed particle phase that is expected to be more
representative of the actual dispersion in solution [22].
Cryo-TEM images of Luc + MNPs (Fig. 2c) show the
nanocomposite diameter ranging from 40–50 nm were
observed, supporting the addition of firefly luciferase to
the nanoparticles. Luc + MNP showed as distinct core–
shell morphology with a lighter- colored luciferase shell
(~5 nm) surrounding the darker CA-MNP core. (Note
that the lighter-colored strands between and near some
of the Luc + MNP structures are likely luciferase strands
which have extended/unfolded during the cryogenic
sample preparation and are partially coordinated with the
Luc + MNPs as an effect of rapid temperature changes as
discussed elsewhere [23]). These TEM images not only
validate the formation of the Luc + MNP complexes, but
also demonstrate the formation of core-shell structures,
as has been reported elsewhere for luciferase complexation with silver nanoparticles [24].
Dynamic light scattering (DLS) was used to evaluate
the diameter of CA-MNP both before (31.5 ± 1.5 nm)
and after (119.7 ± 23.9 nm) firefly luciferase adsorption.
The increase in particle diameter and particle size distribution (Additional file 1: Figures S1, S2) is attributed to
the addition of a firefly luciferase shell. While the trends
are the same, the DLS particle sizes are larger than those
measured using TEM. However, the DLS data is expected
to be more representative of the in situ particle sizes
since the DLS data is collected in the luciferase enzyme
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hydrated state and the DLS experiment gives statistically
significant data for the average particle sizes and particle
size distributions.
Electrostatic charge on nanoparticle surfaces can be
used to confirm the surface modification of nanoparticles, including binding with enzymes and proteins [24].
Here, phase-angle light scattering (PALS) measurements
were used to study the surface charge of CA-MNPs at
neutral pH before and after the addition of firefly luciferase on the CA-MNP periphery. For CA-MNPs, PALS
data shows a negative ζ-potential (−21.5 ± 2.0 mV). After
addition of luciferase, the ζ-potential of nanoparticles
increased to 4.5 ± 0.5 mV. The shift from negative to positive ζ-potential values confirms that luciferase is present
as a shell on the exterior in the Luc + MNPs complexes.
Spermatozoa labeling and bioluminescence imaging

After confirming the chemical and morphological characteristics of Luc + MNPs using a variety of in situ
analyses, the newly synthesized Luc + MNP nanoparticles were evaluated for sperm labeling and imaging
with the aid of in situ bioluminescence imaging (BLI)
experiments to demonstrate the bioluminescent properties. Labeling procedures and imaging were followed
as previously described [2, 15]. In this study, purified
motile boar spermatozoa were prepared and labeled
without or with the CA-MNP and Luc + MNP nanoparticles. Unlabeled sperm samples and samples labeled
with BRET-QD were used as negative and positive controls, respectively. Briefly, PBS-suspended spermatozoa
were labeled and then washed three times by centrifugation to remove excess nanoparticles. All sperm pellets
and their corresponding supernatants were mixed with
luciferase substrate (coelenterazine) and immediately
imaged (In Vivo Imaging System, IVIS 100; Xenogen;

Fig. 2 Citric acid-modified magnetic nanoparticles (CA-MNPs) were observed a with TEM to be ~17 nm in diameter and b with cryo-TEM to be
similarly sized but dispersed. After the addition of the luciferase, c cryo-TEM shows that the Luc + MNP are larger (~ 40–50 nm) with a core–shell
structure where a lighter luciferase shell surrounds the darker CA-MNP core; the inset shows a single magnified core–shell Luc + MNP structure
showing the luciferase shell thickness is ~5 nm
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Fig. 3). Compared to CA-MNP and supernatant, BLI signal intensity was higher in spermatozoa samples incubated with Luc + MNPs. For the Luc + MNP sample,
relative BLI intensities for the sperm pellet and supernatant indicate that while excess unbound MNPs are present in the supernatant, there is a higher signal from the
sperm pellet and indicates positive interactions between
the spermatozoa and Luc + MNP. Significantly lower
BLI intensities were observed for the CA-MNP sample
and supernatant as compared with neat luciferase and
Luc + MNP samples (Fig. 3). Therefore, the strong BLI
signal from the Luc + MNP coupled with spermatozoa,
before and after centrifugation, confirms the presence
and viability of the MNP- bound luciferase (Luc + MNP)

Fig. 3 Bioluminescence imaging (BLI) of CA-MNP, Luc + MNPs,
and Luc only. Spermatozoa were labeled in PBS solution and then
centrifuged. Sperm pellets from the Luc + MNPs, and Luc samples,
and their corresponding supernatants (sCA-MNP, sLuc + MNP),
were separately imaged after supplementation with coelenterazine.
(Note that measurements were performed on 1.5 mL centrifuge
tubes with ~50 µL of sample.) a Sample images with light (BLI) signal
intensities shown as a gradient color scale. b Quantified BLI signals
(mean ± sem). Asterisk indicates significant difference from CA-Luc
Control (ANOVA-2, P < 0.05, N = 4 replicates)
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as an image agent. The BLI for neat luciferase (with coelenterazine added) is presented as a positive control, and
as expected shows the highest BLI signal (Luc, Fig. 3a),
at least in part because the luciferase is not split between
sample and supernatant aliquots. Spermatozoa in the
Luc + MNP sample showed slightly lower BLI levels as
compared to the luciferase alone, which is certainly due
to substantial levels of Luc + MNP in the supernatant.
After in situ bioluminescence imaging, the sperm
Luc + MNP labeled samples were smeared on microscope slides and light emissions imaged using two microscopic techniques, UV–visible-NIR and laser confocal.
Using a series of in situ experiments, it was observed that
the Luc + MNP and CA-MNP nanoparticles were in a
non-aggregated state. It should be noted that the presence of luciferase, in particular while in the presence of
biological media such as PBS (which was the as- received
solution for boar spermatozoa specimens), could cause
aggregation in situ and during drying [25–28]. To examine these issues, we collected an additional TEM image
under non-cryo conditions (i.e., evaporative drying) that
revealed possible aggregation of Luc + MNPs which
could be a result of the PBS solution and/or the drying
process (Additional file 1: Figure S3). Despite this observation, we can still investigate one of the primary objectives of this study—a preliminary evaluation of binding
interactions between Luc + MNPs and boar spermatozoa.
After Luc + MNPs are added to boar sperm, round nanoparticle structures were observed on the surface of the
sperm cells using the UV–vis-NIR microscope (see arrow
heads, Fig. 4). Control experiments for QDs (Additional
file 1: Figure S4) and neat spermatozoa cells (Additional
file 1: Figure S5) were conducted, which reveal that the
round nanoparticle structure are the MNP. While these
preliminary finding confirm that the nanoparticles interact with the cell surface (Fig. 4), the MNP density per cell,
cell and MNP agglomeration, and time-dependency of the
cell-MNP binding will be examined in future work.
To gain a better understanding of the nanoparticle
interactions with spermatozoa, laser confocal microscopy
measurements were performed (Fig. 5). Preliminary analyses on the as-synthesized Luc + MNPs were used as a
control experiment to observe any aggregated structures
in the presence of PBS (Fig. 5a); some large-scale particle aggregates, ranging from 1.5–2 microns in diameter,
were observed. This confirms the TEM results showing
that, unlike the cryo-TEM or in situ characterization
techniques, aggregation can be caused by PBS and/or
the drying conditions used for collecting non-cryo TEM
images. Within the aggregated structures, the core–shell
structure of the nanoparticles was observed, showing
that the luciferase shell is still present on the surface of
the MNPs.
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Fig. 4 Micrograph of mammalian spermatozoa cells incubated with
Luc + MNPs. Arrow heads indicate Luc + MNP locations and show the
nanoparticles in close proximity to the spermatozoa, with multiple
nanoparticles attached to head and/or tail of the sperm cells. Scale
bar 10 microns

To obtain some preliminary information on the location and number of interactions between Luc + MNPs
and a spermatozoon and on the effect of the shell composition (Luc or CA) on spermatozoa labeling, two separate experiments are discussed. A representative image
showing interactions between CA-MNPs and a spermatozoon revealed that the CA-coated particles bind with
the tail of the spermatozoon (Fig. 5b). Experiments conducted on Luc + MNPs showed that the particles bind at
multiple positions, near the head and/or the tail, of the
spermatozoon (Fig. 5c). While these results preliminarily
indicate that there may be different interactions between
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the surface-modified MNPs and spermatozoa based on
the exterior (shell) functionality (CA or Luc), the location dependency and density of spermatozoon binding
based on different surface modifiers should be extensively investigated in future efforts. A control experiment was performed, and no small or large particles were
observed (Fig. 5d). Adding to this control experiment,
the magnetic nature of the attached particles was confirmed using a third microscopy technique, atomic and
magnetic force microscopy (AFM/MFM), which showed
magnetic domains inside the nanoparticle structure
(Fig. 6) [27]. The AFM/MFM results demonstrate that the
Luc + MNPs retain their magnetic properties even after
they are attached to a spermatozoon (Fig. 6b).
This study demonstrates that luciferase-magnetic
nanoparticle (Luc + MNP) composites and citric acidmagnetic nanoparticles (CA-MNPs) can be used for
binding and imaging of spermatozoa. Luc + MNPs
adds additional advantages as different locations on the
sperm are targeted for binding and enhanced bioluminescence imaging and tracking can be performed. At
this point, their additional magnetic functionality, for
example to manipulate the sperm cells, was not examined; however, it will be the focus of future studies. This
preliminary study shows that luciferase-modified magnetic nanoparticles is a magnetic platform that can be
utilized as a possible alternative for QD-based bioimaging, and which also has potential for magnetic cellular
manipulation and MRI applications. In addition, this
nanocomposite system will allow for alternate or secondary surface functionality to be included, as desired,
through tailored surface-modification techniques.
Future studies could include examinations of the (1)

Fig. 5 a Magnetic nanoparticles (MNPs) modified with luciferase (Luc + MNP) were observed as 1.5–2 µm aggregates under PBS and dried sample
conditions. b MNP-CA and c Luc + MNP bound at different locations (head and tail) onto spermatozoa. d Spermatozoa incubated in PBS show no
particles or aggregates. Arrows indicate MNP locations and scale bars correspond to 5 µm
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Fig. 6 Atomic force and magnetic force microscopy (AFM/MFM) reveals a adsorption of Luc + MNP on a spermatozoon head (AFM height image)
and b the magnetic properties of the adsorbed Luc + MNP (arrow head) (MFM lift-phase signal image)

optimum ratio(s) between luciferase and CA-MNPs,
(2) adsorption process mechanism(s) and the resultant Luc + MNP complex structures using experimental and computational techniques [29], Luc + MNP/
cell binding ratios using in vivo/vitro microscopy techniques [30], toxicity and biocompatibility effects on
the as-synthesized Luc + MNPs [31], and alternate
nanoscale fluorescent dyes which are emerging in cell
labeling [32].

Methods

Conclusion
Magnetic nanoparticles were synthesized and complexed with firefly (Photinus pyralis) luciferase
enzyme to produce a multifunctional nanocomposite,
Luc + MNP. Inherent bioluminescence in the presence of mammalian spermatozoa was examined, showing Luc + MNP as a promising candidate to enhance
or replace some current bioimaging technologies. By
utilizing FDA-approved iron oxide magnetic nanoparticles and a natural enzyme, such as firefly luciferase,
this nanocomposite has potential for a lower toxicity
than quantum dots, as well as the ability to magnetically
manipulate cells and track them in vivo. The results presented here demonstrate the possibility of using this
luciferase-modified magnetic nanoparticle for cellular
binding and imaging. Additional studies on the optimum concentrations and solution composition for cell
binding and viability, cell tracking and magnetic manipulation, and time-dependence of the labeling and bioluminescence will allow for a better understanding of the
parameters for implementing Luc + MNPs for assisted
reproductive technologies. Other activation mechanisms (beyond coelenterazine addition), such as ATP/
Mg2+ sources, are also interesting avenues for future
studies.

In brief, iron oxide magnetic nanoparticles (MNPs) were
synthesized by combining 10.014 g of iron chloride (II)
and 2.665 g of iron chloride (III) in the presence of 0.7 M
ammonium hydroxide (high pH) at 60 °C under an inert
atmosphere with the aid of mechanical stirring for a final
volume of 250 mL. After 30 min of reaction, iron oxide
magnetic nanoparticles were separated with an external magnet and washed twice with deionized water. The
separated particles were stabilized using a 0.02 g/mL citric acid (CA) solution at 90 °C for 1 h [33]. CA-stabilized
magnetic nanoparticles (CA-MNP) were then separated
and washed with water twice using an external magnet. CA-MNPs were then added to 100 mL of water and
centrifuged at 14,500 rpm until a black precipitate was
formed. For Luc adsorption onto CA-MNP, ~10 mg/L
CA-MNP was co-incubated with the luciferase (Luc)
enzyme (200 mg/L) at ambient temperature to avoid
enzyme deactivation. The resultant Luc + MNP complexes, and the CA-MNP samples, were characterized
using dynamic light scattering (DLS), Fourier transform
infrared (FTIR) spectroscopy, transmission electron
microscopy (TEM), and zeta potential measurements.
Both the Luc + MNP and CA-MNP control samples
were assessed using bioluminescence imaging (BLI) in
the presence of spermatozoa.

Materials

Iron (II) chloride (Sigma Aldrich, 98 %), iron (III) chloride (Alfa Aesar, 98 %), ammonium hydroxide (Acros,
28–30 %), and luciferase from Photinus pyralis (firefly)
were used as received (Sigma Aldrich, 98 %). Ultrapure
type I water (EMD Millipore®) was utilized in the preparation of all experimental solutions.
Luciferase‑CA‑MNPs synthesis
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Magnetic nanoparticle characterization techniques
Attenuated total reflectance‑Fourier transform infrared
spectroscopy (ATR‑FTIR)
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Confocal, fluorescence, and atomic/magnetic‑force
microscopy imaging

A ZetaPALS instrument (Brookhaven Instruments Corporation, Holtsville, NY) was used for dynamic light
scattering (DLS) and zeta potential measurements. A
minimum of 5 measurements were collected for each
sample.

Aliquots of labeled spermatozoa incubated with only PBS
(negative control), CA-MNP in PBS, and Luc + MNP in
PBS were placed onto microscope slides to evaluate their
optical and fluorescence emission using a Laser confocal
microscope (LSM510; Carl Zeiss) and a Nikon Eclipse
Ni fluorescence microscope, respectively. For epifluorescence microscopy, aliquots of spermatozoa labeled with
QD were also prepared (positive control; Additional
file 1: Figure S4), as well as neat spermatozoa (Additional file 1: Figure S5). Images were taken with a Nikon
CFI Plan Fluor Ph2 DLL 40× objective Pan Fluor 40×,
Ph2 DLL. A Nikon B-2E/C fluorescence filter (96311,
green: 465–495 nm excitation and 515–555 nm emission) and Semrock BrightLine® QD655-C single-band
filter (395–460 nm excitation and 640–680 nm emission)
was used to observe the Luc + MNP and QD nanoparticles, respectively. For AFM/MFM analyses, a drop of
Luc + MNPs combined with spermatozoa was placed
onto a glass slide and allowed to air dry. A Dimension
Icon® atomic force microscope with a Bruker® MESP®
tip, under magnetic force microscopy mode, was utilized
for AFM/MFM magnetic analysis with a minimum lift
height of 200 nm (Fig. 6).

Spermatozoa preparation and labeling

Bioluminescence imaging (BLI) analysis

Motile boar spermatozoa were selected from freshly
collected samples (Prestage Farms, West Point, MS,
USA) as described previously [34]. The spermatozoa
(2 × 108 sperm/mL) were incubated with 20 μL of CAMNP and Luc + MNP solution stocks as described in
4.2. The positive and negative controls consisted of
spermatozoa incubated with a 1 nM quantum dot (QD;
Additional file 1: Figure S4) solution and with phosphate buffered saline (PBS; Additional file 1: Figure S5),
respectively.
For the positive control study, a stock solution of CdSe/
ZnS core–shell structure QD (500 nM in Tris buffer)
cross-linked to Renilla luciferase (BRET) and nonaarginine R9 peptide was purchased from Zymera Inc.
(San Jose, CA, USA). The BRET-QD complex is a selfilluminating nanoparticle that emits light under incubation with coelenterazine (luciferase substrate) and
exhibits intense fluorescence with red-shifted emission
(655 nm) following excitation (Additional file 1: Figure
S4). Mixtures were incubated at 37 °C for 30 min, and
then washed three times with PBS using centrifugation
(1000g, 3 min). Supernatants containing excess QD were
removed and 50 μL of each was retained for BLI. In parallel, sperm pellets were suspended with 50 μL PBS for
experiments.

BLI analysis was performed as previously reported [2].
Briefly, 4 μg of coelenterazine was added to each of the
cell suspensions and supernatants, and gently mixed.
All samples were imaged within 10 min using an IVIS
100 Bioluminescence Imaging System (Caliper Life Sciences, Hopkinton, MA, USA) with a 1 min acquisition
time and no filter. All images were analyzed using Living
Image Software (v2.50, Caliper Life Sciences). Measurements were made by drawing a primary region of interest (ROI) on the bioluminescence images in each sample
tube. A secondary ROI surface without sample tubes was
measured as the background, and this value subtracted
from the primary ROI light emission to correct for autofluorescence. The bioluminescence data are presented as
total light emission (photons per second).

A 6700 Nicolet FTIR spectrophotometer from Thermo
Electron Corporation with a He–Ne laser MCT-A*
detector was used for all measurements. To collect ATRFTIR spectra, a Miracle-ATR™ external accessory with a
diamond-ZnSe crystal (PIKE Technologies) was used for
data collection.
Transmission electron microscopy (TEM)

A JEOL 2100 operated at 200 kV was used for high- resolution imaging (Additional file 1: Figure S3). Cryo-TEM
images were collected with a JEOL 1400 Biological TEM
using a Gatan, Inc. Cryoplunge™ adapter (Fig. 2). For all
non-cryo TEM imaging, a drop of the liquid samples was
deposited on a carbon Formvar® Cu 300 mesh grid.
Dynamic light scattering (DLS) and zeta potential
measurements

Additional file
Additional file 1. Figure S1. Hydrodynamic diameter for in-house
synthesized CA-MNPs, as measured by DLS number intensity (5 replicates).
An average diameter of 31.5 ± 1.5 nm was measured for the in-house synthesized CA-MNPs; Figure S2. Hydrodynamic diameter for Luc + MNP, as
measured by DLS number intensity (5 replicates). After luciferase addition,
the number intensity particle diameter measured increased as compared
to CA-MNPs. The larger particle diameter matches the size increases
observed by TEM, and confirms that luciferase is bound onto the CA-MNP.
Future studies will examine the optimum ratio between luciferase and CAMNPs, the mechanisms of the adsorption process(es), and the resultant

Vasquez et al. J Nanobiotechnol (2016) 14:20

Luc + MNP complex structures. Figure S3. Magnetic nanoparticles
(Luc + MNPs) aggregated under the presence of PBS solutions and in a
conventional TEM characterization where like in the confocal, epifluorescence, and atomic/magnetic force microscopy results dried samples were
used for imaging Luc + MNPs interacting with spermatozoa with the
drying process contributing to the aggregation observed. Figure S4.
QDs nanoparticles combined with spermatozoa showed binding at different sites on the cells (arrows) as well as unlabeled cells (arrow heads). Scale
bar 10 micrometers. The QD associated with spermatozoa are attached at
multiple and different sites on the cell; examples are marked with arrows.
Note that not allspermatozoa were labeled using the QD method; examples of these unlabeled cells are marked with arrow heads. Figure S5.
Neat spermatozoa observed with an epifluorescence microscope. Scale
bar 10 microns. Neat spermatozoa were characterized to demonstrate
that coelenterazine and PBS neither contain nor cause the development of the observed round nanoscale structures in the CA-MNPs and
Luc + MNP samples (Figs. 4 and 5).
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